NASDAQ: APTX       Aptinyx Inc
Last Price Today's Change   Day's Range   Trading Volume
2.42   +0.05 (2.11%)  2.376 - 2.48  95,492


Avg Volume (4 weeks):142,036
4 Weeks Range:2.32 - 2.78
4 Weeks Price Volatility (%):
52 Weeks Range:2.16 - 6.47
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3939  5748  937  676 

Top 10 Active Counters
 RWLK 2.59+1.29 
 SQQQ 8.13-0.02 
 NNVC 6.19+2.40 
 SPY 433.63-0.41 
 CEI 1.60+0.05 
 FAMI 0.21-0.003 
 CRVS 8.53+2.36 
 UBER 44.595+4.805 
 UVXY 25.86-1.45 
 LCID 26.941+2.871